Clinical

Dataset Information

0

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer


ABSTRACT: This is a phase II Randomized comparison clinical trial of activated CIK armed with anti-CD3-MUC1 bispecific antibody for advanced colorectal cancer. And the aim of this research is to study the clinical efficacy and safety of activated CIK armed with anti-CD3-MUC1 bispecific antibody for colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Advanced Colorectal Cancer

PROVIDER: 2272861 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-09-12 | GSE212740 | GEO
2020-11-12 | GSE159547 | GEO
| PRJNA580267 | ENA
2011-04-29 | E-GEOD-28940 | biostudies-arrayexpress
2023-04-07 | GSE97581 | GEO
2019-09-06 | GSE136958 | GEO
2021-11-04 | GSE187440 | GEO
2021-11-04 | GSE187082 | GEO
2021-11-04 | GSE187404 | GEO
2021-11-04 | GSE187920 | GEO